NYSE : IQV
IQVIA Holdings Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 267.33 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 44.06B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 44.06B |
| Enterprise Value | 57.95B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 164.80M |
| Shares Outstanding | 164.80M |
| Shares Change (YoY) | -3.88% |
| Shares Change (QoQ) | -0.18% |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 98.23% |
| Float | 156.45M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 32.38 |
| Forward PE | 19.36 |
| PS Ratio | 2.54 |
| Forward PS | 2.41 |
| PB Ratio | 6.62 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.19 |
| P/OCF Ratio | 16.10 |
| PEG Ratio | 1.73 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 41.57 |
| EV / Sales | 3.35 |
| EV / EBITDA | 18.58 |
| EV / EBIT | 24.10 |
| EV / FCF | 27.87 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.83 |
| Quick Ratio | 0.74 |
| Debt / Equity | 2.40 |
| Debt / EBITDA | 4.97 |
| Debt / FCF | 7.85 |
| Interest Coverage | 3.06 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 21.39% |
| Return on Assets (ROA) | 5.08% |
| Return on Invested Capital (ROIC) | 9.89% |
| Return on Capital Employed (ROCE) | 10.59% |
| Weighted Average Cost of Capital (WACC) | 8.91% |
| Revenue Per Employee | $184,160 |
| Profits Per Employee | $14,830 |
| Employee Count | 94,000 |
| Asset Turnover | 0.58 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 254.00M |
| Effective Tax Rate | 15.37% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +22.72% |
| 50-Day Moving Average | 266.09 |
| 200-Day Moving Average | 209.52 |
| Relative Strength Index (RSI) | 49.00 |
| Average Volume (20 Days) | 1,347,366 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.99M |
| Short Previous Month | 4.12M |
| Short % of Shares Out | 1.82% |
| Short % of Float | 1.91% |
| Short Ratio (days to cover) | 1.92 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 17.31B |
| Gross Profit | 5.72B |
| Operating Income | 2.40B |
| Pretax Income | 1.65B |
| Net Income | 1.39B |
| EBITDA | 3.12B |
| EBIT | 2.40B |
| Earnings Per Share (EPS) | $8.25 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.42B |
| Total Debt | 16.31B |
| Net Cash | -13.89B |
| Net Cash Per Share | -$84.30 |
| Equity (Book Value) | 6.79B |
| Book Value Per Share | 40.41 |
| Working Capital | -1.33B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.74B |
| Capital Expenditures | -657.00M |
| Depreciation & Amortization | 714.00M |
| Net Borrowing | 1.26B |
| Free Cash Flow | 2.08B |
| FCF Per Share | $12.62 |
Margins
| Measure | Value |
|---|
| Gross Margin | 33.07% |
| Operating Margin | 13.89% |
| Pretax Margin | 9.55% |
| Profit Margin | 8.05% |
| EBITDA Margin | 18.01% |
| EBIT Margin | 13.89% |
| FCF Margin | 12.01% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.88% |
| Shareholder Yield | 3.88% |
| Earnings Yield | 3.09% |
| FCF Yield | 4.72% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $311.47 |
| Price Target Difference | 16.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | 6.75% |
| EPS Growth Forecast (3Y) | 10.51% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.04 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |